| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Inozyme Pharma, Inc. | Director | Stock Option (right to buy) | 28K | 18 Jun 2024 | Direct | ||
| Lexeo Therapeutics, Inc. | Director | Stock Option (right to buy) | 25K | 26 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LXEO | Lexeo Therapeutics, Inc. | 26 Jun 2025 | 1 | $0 | 4 | Director | 30 Jun 2025, 17:00 |
| LXEO | Lexeo Therapeutics, Inc. | 25 Jun 2024 | 1 | $0 | 4 | Director | 27 Jun 2024, 17:02 |
| INZY | Inozyme Pharma, Inc. | 18 Jun 2024 | 1 | $0 | 4 | Director | 20 Jun 2024, 16:14 |
| LXEO | Lexeo Therapeutics, Inc. | 02 Feb 2024 | 1 | $0 | 4 | Director | 06 Feb 2024, 17:58 |
| LXEO | Lexeo Therapeutics, Inc. | 02 Nov 2023 | 0 | $0 | 3 | Director | 02 Nov 2023, 21:26 |
| INZY | Inozyme Pharma, Inc. | 13 Jun 2023 | 1 | $0 | 4 | Director | 15 Jun 2023, 16:05 |
| INZY | Inozyme Pharma, Inc. | 10 Jun 2022 | 1 | $0 | 4 | Director | 14 Jun 2022, 07:47 |
| INZY | Inozyme Pharma, Inc. | 23 Jun 2021 | 1 | $0 | 4 | Director | 24 Jun 2021, 16:11 |